Third-Quarter 2023 Revenues of $13.2 Billion Expected Decline in Paxlovid and Comirnaty(1) Revenues Drove 41% Operational Decrease in Third-Quarter 20...
Revenue of $671 million; (6)% reported growth; (7)% organic growth; 1% non-COVID organic growth GAAP EPS of $0.08; Adjusted EPS from continuing oper...
Q3 2023: Net sales of $476 million (-5% at actual rates, -6% at constant exchange rates, CER); diluted EPS of $0.34 and adjusted diluted EPS of $0.50 // Ne...
Third-quarter 2023 total net sales were $632.1 million, a decrease of 7.1 percent compared to $680.8 million reported for the third quarter of 20...
In the bustling halls of CPHI Barcelona, BioPharma BoardRoom had the privilege to sit down with Lars Petersen, the President and CEO of FUJIFILM Diosynth B...
In a rapidly evolving world where data and artificial intelligence have become paramount, BioAsia 2024 presents a theme that transcends traditional boundar...
Third Quarter 2023 Highlights Third quarter revenue was $10.57 billion, 1% lower versus the same quarter last year. Core organic revenue growth was 1%. ...
Transitional year 2023 managed well so far thanks to resilient business model Medium-term growth targets confirmed Merck expects continued growth also ...
Transformation into a “pure-play” innovative medicines business is complete, with the spin-off of Sandoz; commentary below is on continuing o...
Group sales grow by 1%1 at constant exchange rates (CER) in the first nine months, showing a strong increase of 7% in the third quarter Excluding COVID-...
Agilent Technologies Inc. announced the company’s near and long-term targets for reaching net-zero greenhouse gas emissions have been approved by the...
Sales revenue in constant currencies down 16.4 percent, excluding Covid-19-related business down slightly above 10 percent; underlying EBITDA marg...
Dr. Ali will be spearheading all aspects of MHTC’s operations, ensuring its commitment to facilitating and promoting the nation’s healthcare tr...
Kasim Kutay, CEO of Novo Holdings, said: “With her extensive market knowledge and executive experience in the pharmaceutical and life science industr...
© 2025 Biopharma Boardroom. All Rights Reserved.
